Details for New Drug Application (NDA): 210189
✉ Email this page to a colleague
NDA 210189 describes PHYTONADIONE, which is a drug marketed by Cipla, Dr Reddys, Glaxosmithkline, Intl Medication, Agnitio, Amneal Pharms Co, Sciegen Pharms Inc, and Zydus Lifesciences, and is included in nine NDAs. It is available from fifteen suppliers. Additional details are available on the PHYTONADIONE profile page.
The generic ingredient in PHYTONADIONE is phytonadione. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
The generic ingredient in PHYTONADIONE is phytonadione. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
Summary for 210189
| Tradename: | PHYTONADIONE |
| Applicant: | Zydus Lifesciences |
| Ingredient: | phytonadione |
| Patents: | 0 |
Pharmacology for NDA: 210189
| Physiological Effect | Increased Prothrombin Activity Reversed Anticoagulation Activity |
Suppliers and Packaging for NDA: 210189
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PHYTONADIONE | phytonadione | TABLET;ORAL | 210189 | ANDA | Northstar Rx LLC. | 16714-973 | 16714-973-02 | 1 BOTTLE in 1 CARTON (16714-973-02) / 30 TABLET in 1 BOTTLE |
| PHYTONADIONE | phytonadione | TABLET;ORAL | 210189 | ANDA | Zydus Pharmaceuticals USA Inc. | 70710-1014 | 70710-1014-1 | 1 BOTTLE in 1 CARTON (70710-1014-1) / 100 TABLET in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Feb 20, 2019 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
